Benign prostatic hyperplasia: Edited by Jean de la RosetteGreenlight laser in benign prostatic hyperplasia: turning green into goldAlivizatos, Gerasimos; Skolarikos, AndreasAuthor Information Second Department of Urology, Athens Medical School, Sismanoglio Hospital, Athens, Greece Correspondence to Gerasimos Alivizatos, MD, PhD, FEBU, Associate Professor in Urology, Athens Medical School, Second Urology Department, Sismanoglio Hospital, Athens, Greece Tel: +30 210 8039310; fax: +30 210 7219714; e-mail: [email protected] Current Opinion in Urology: January 2008 - Volume 18 - Issue 1 - p 46-49 doi: 10.1097/MOU.0b013e3282f0d63b Buy Metrics Abstract Purpose of review The purpose of this review is to present recent clinical data published upon the photoselective vaporization of the prostate procedure and introduce new ideas about the future influence of this new technology upon the treatment of benign prostatic hyperplasia. Recent findings Published studies have provided significant evidence that the photoselective vaporization of the prostate laser procedure is efficient, safe, easy to learn and early results show that it can compete with transurethral resection of the prostate. The major advantages of this technique are that it is a bloodless procedure, the patient goes home after a few hours and it can be applied to all patient categories. The cost of the photoselective vaporization of the prostate procedure is being investigated and a few studies addressing this issue seem to conclude that this surgical option is a cost effective decision. Lately, thoughts about early surgical intervention with the photoselective vaporization of the prostate laser are being expressed but properly designed studies are needed. Summary The photoselective vaporization of the prostate laser procedure is getting worldwide fast recognition and it is the first time that transurethral resection of the prostate and open prostatectomy are being threatened. The cost of this procedure is being examined but it is difficult to draw solid conclusions since reimbursement strategies differ between various countries. © 2008 Lippincott Williams & Wilkins, Inc.